pharmaceutical product development

Dexcel Pharma USA is a privately owned specialty pharmaceutical company focused on identifying, developing, and marketing quality prescription pharmaceutical products. Formerly known as Edenbridge Pharmaceuticals, it was acquired by Dexcel Pharma in 2022 and rebranded as Dexcel Pharma USA in 2024. It offers generic, branded, and specialty products across therapeutic areas including oncology, cardiology, neurology, gastroenterology, and urology, and is dedicated to rare diseases such as multiple myeloma and Gaucher disease.

Read more

business development partnershipsmarketing of prescription pharmaceuticals